178 related articles for article (PubMed ID: 38001367)
41. Assessment of intravitreal ocriplasmin treatment for vitreomacular traction in clinical practice.
Schumann RG; Langer J; Compera D; Luedtke K; Schaumberger MM; Kreutzer T; Mayer WJ; Wolf A; Priglinger SG
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2081-2089. PubMed ID: 28755165
[TBL] [Abstract][Full Text] [Related]
42. [Ocriplasmin as a treatment option for symptomatic vitreomacular traction with and without macular hole. First clinical experiences].
Maier M; Abraham S; Frank C; Feucht N; Lohmann CP
Ophthalmologe; 2015 Dec; 112(12):990-4. PubMed ID: 26062717
[TBL] [Abstract][Full Text] [Related]
43. A novel spectral-domain optical coherence tomography model to estimate changes in vitreomacular traction syndrome.
Codenotti M; Iuliano L; Fogliato G; Querques G; Bandello F
Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1729-35. PubMed ID: 24764038
[TBL] [Abstract][Full Text] [Related]
44. Short-term changes in posterior vitreous cortex following intravitreal ocriplasmin for symptomatic vitreomacular traction syndrome: a prospective study.
Cacciamani A; Gattegna R; Pileri M; Di Nicola M; Bardanzellu S; Facciolo G; Cosimi P; Govetto A; Scarinci F
Int Ophthalmol; 2020 Jan; 40(1):185-193. PubMed ID: 31565760
[TBL] [Abstract][Full Text] [Related]
45. PREDICTIVE FACTORS ASSOCIATED WITH THE VISUAL PROGNOSIS AFTER SURGERY FOR IDIOPATHIC VITREOMACULAR TRACTION.
Qi B; Yang X; Yu Y; Zhang K; Wu X; Wang X; Jia Q; Feng X; Liu W
Retina; 2024 Mar; 44(3):429-437. PubMed ID: 37883595
[TBL] [Abstract][Full Text] [Related]
46. Spectral-domain optical coherence tomography features in fellow eyes of patients with idiopathic macular hole.
Chhablani J; Kumar K; Ali TR; Narayanan R
Eur J Ophthalmol; 2014; 24(3):382-6. PubMed ID: 24242224
[TBL] [Abstract][Full Text] [Related]
47. Vitrectomy with or without internal limiting membrane peeling for each stage of myopic traction maculopathy.
Taniuchi S; Hirakata A; Itoh Y; Hirota K; Inoue M
Retina; 2013; 33(10):2018-25. PubMed ID: 23975004
[TBL] [Abstract][Full Text] [Related]
48. Tomographic features and surgical outcomes of vitreomacular traction syndrome.
Yamada N; Kishi S
Am J Ophthalmol; 2005 Jan; 139(1):112-7. PubMed ID: 15652835
[TBL] [Abstract][Full Text] [Related]
49. Resolution of outer retinal abnormalities in eyes with vitreomacular traction without macular hole in the OASIS trial.
Thomas AS; Duchateau L; Kozma-Wiebe P; Jaffe G
Br J Ophthalmol; 2023 Jul; 107(7):1012-1017. PubMed ID: 35288439
[TBL] [Abstract][Full Text] [Related]
50. Full-thickness macular hole formation in proliferative diabetic retinopathy.
Tsui MC; Hsieh YT; Lai TT; Lai CT; Lin HC; Ho TC; Yang CH; Yang CM; Wang LC
Sci Rep; 2021 Dec; 11(1):23839. PubMed ID: 34903770
[TBL] [Abstract][Full Text] [Related]
51. Posterior vitreous detachment and macular hole formation in myopic foveoschisis.
Matsumura N; Ikuno Y; Tano Y
Am J Ophthalmol; 2004 Dec; 138(6):1071-3. PubMed ID: 15629315
[TBL] [Abstract][Full Text] [Related]
52. Vitreomacular traction quantitative cutoffs for the assessment of resolution after ocriplasmin intravitreal treatment.
Arrigo A; Calamuneri A; Bordato A; Aragona E; Pierro L; Bandello F; Battaglia Parodi M
Sci Rep; 2020 Oct; 10(1):17583. PubMed ID: 33067537
[TBL] [Abstract][Full Text] [Related]
53. Lamellar macular hole in diabetic retinopathy.
Kuo BI; Yang CM; Hsieh YT
Eur J Ophthalmol; 2021 Jan; 31(1):166-172. PubMed ID: 31595782
[TBL] [Abstract][Full Text] [Related]
54. Recovery course of foveal microstructure in the nonsurgical resolution of full-thickness macular hole.
Mansour HA; Uwaydat SH; Parodi M; Jürgens I; Smiddy W; Ellabban AA; Schwartz SG; Foster RE; Ascaso J; Leoz MS; Belotto S; Mateo J; Olivier-Pascual N; Lima LH; Navea A; Neila EMR; Castillo RA; Alaman AS; Mansour AM;
Graefes Arch Clin Exp Ophthalmol; 2022 Oct; 260(10):3173-3183. PubMed ID: 35467125
[TBL] [Abstract][Full Text] [Related]
55. Natural course of macular retinoschisis in highly myopic eyes without macular hole or retinal detachment.
Shimada N; Ohno-Matsui K; Baba T; Futagami S; Tokoro T; Mochizuki M
Am J Ophthalmol; 2006 Sep; 142(3):497-500. PubMed ID: 16935601
[TBL] [Abstract][Full Text] [Related]
56. Subfoveal Lucency after Treatment of Vitreomacular Traction without Macular Hole in the Phase 3 Trials of Ocriplasmin Vitreolysis.
Thomas AS; Folgar FA; Jaffe GJ; Toth CA; Mahmoud TH
Ophthalmol Retina; 2019 Jan; 3(1):42-52. PubMed ID: 30929816
[TBL] [Abstract][Full Text] [Related]
57. Surgical outcome of full-thickness macular hole secondary to tractional retinal detachment in proliferative diabetic retinopathy.
Babu N; Kohli P; Mishra C; Rajan RP; Kumar K; Ramasamy K; Dara R; Lakshmi CC
Indian J Ophthalmol; 2021 Nov; 69(11):3302-3307. PubMed ID: 34708793
[TBL] [Abstract][Full Text] [Related]
58. Development of full-thickness macular hole despite previous posterior vitreous detachment and vitrectomy for retinal detachment: two cases.
Sheth HG; Bainbridge J
Eur J Ophthalmol; 2008; 18(6):1025-7. PubMed ID: 18988183
[TBL] [Abstract][Full Text] [Related]
59. Spontaneous resolution of vitreomacular traction demonstrated by spectral-domain optical coherence tomography.
Theodossiadis GP; Grigoropoulos VG; Theodoropoulou S; Datseris I; Theodossiadis PG
Am J Ophthalmol; 2014 Apr; 157(4):842-851.e1. PubMed ID: 24445034
[TBL] [Abstract][Full Text] [Related]
60. Outer Retinal Changes Preceding Secondary Macular Hole Formation Years After Vitreomacular Traction Release Demonstrated on Spectral-Domain OCT.
Chin AT; Bonini Filho MA; de Carlo TE; Adhi M; Duker JS
Ophthalmic Surg Lasers Imaging Retina; 2015 Sep; 46(8):880-2. PubMed ID: 26431305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
